-
Protalix BioTherapeutics is an
Israeli pharmaceutical company that
manufactures a plant-based enzyme,
taliglucerase alfa,
which has
received U.S. Food...
- "Dr.
Philip Frost Leads Up To $21
Million Investment In
Protalix Biotherapeutics".
BioSpace. 2006-08-23.
Retrieved 2025-04-17. George, John (March 27,...
-
Iovance Biotherapeutics, Inc. is a
biopharmaceutical startup based in San Carlos, California. The
company works to
develop tumor-infiltrating lymphocyte...
-
Northwest Biotherapeutics, Inc. is a development-stage
American pharmaceutical company headquartered in
Maryland that
focuses on
developing immunotherapies...
-
Excision BioTherapeutics is a
biopharmaceutical company based in San
Francisco focused on
developing gene
therapies against HIV infection. The company...
-
transactions including the
distribution of AgeX
Therapeutics, the
acquisition of
Asterias Biotherapeutics and
conducting management changes which altogether...
-
Barinthus Biotherapeutics plc (formerly
Vaccitech plc) is a
biotechnology company developing immunotherapies for
infectious diseases,
cancer and autoimmune...
- from
AntiVirals to AVI
BioPharma soon with
stock symbol AVII and in July 2012
changed name from AVI
BioPharma to
Sarepta Therapeutics and SRPT respectively...
- Europe.
BioMarin's core
business and
research is in
enzyme replacement therapies (ERTs).
BioMarin was the
first company to
provide therapeutics for mucopolysaccharidosis...
-
Adaptate Biotherapeutics and its antibody-based γδ T cell technology,
reuniting Adaptate and its
former parent company,
GammaDelta Therapeutics, in a single...
